Erratum to: Phase II study of selumetinib (AZD6244,...

Cancer Chemotherapy and Pharmacology 2015 / 1 Vol. 75; Iss. 1

Erratum to: Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer

Hochster, H. S., Uboha, N., Messersmith, W., Gold, P. J., ONeil, B. H., Cohen, D., Denlinger, C., Cohen, S., Leichman, C. G., Leichman, L., Lenz, H.-J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
75
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-014-2625-3
Date:
January, 2015
File:
PDF, 102 KB
english, 2015
Conversion to is in progress
Conversion to is failed